Merit Medical rises as it buys cancer tissue marker maker View Point

Merit Medical Systems

01/04/2026 14:58

** Shares of medical device maker Merit Medical Systems MMSI.O rise 2% to $69.94

** Co says it will buy View Point Medical, which makes tools that help doctors mark and find cancerous tissue during tests and treatment

** Co says the $140 million deal includes $90 million cash upfront and two deferred payments of $25 million each, over the next two years, effectively including debt

** Co says the deal adds products used mainly in breast and soft-tissue cancer detection, helping mark suspicious areas during biopsy to avoid repeat procedures

** Co sees $2–$4 million in added revenue this year and $14–$16 million in 2027

** Including sessions's move, stock down ~20% YTD

 (Reporting by Sahil Pandey in Bengaluru)

 ((Sahil.Pandey@thomsonreuters.com))